GALECTIN THERAPEUTICS INC. Preferred Stock, Shares Outstanding
GALECTIN THERAPEUTICS INC. (GALT) had Preferred Stock, Shares Outstanding of 1.19 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Outstanding 1.19M shares.
- 2026-03-31: Preferred Stock, Shares Outstanding 1.19M shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 1.21M shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 1.21M shares.
| Period end | Preferred Stock, Shares Outstanding | Preferred Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 1.19M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 1.19M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 1.21M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 1.21M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 1.21M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 1.24M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 1.24M shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 1.24M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 1.24M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 1.24M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 1.24M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 1.26M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 1.26M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.26M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 1.26M shares 10-K · filed 2024-03-29 | |
| 2022-09-30 | 1.26M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 1.26M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 1.30M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 1.30M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 1.30M shares 10-Q · filed 2021-11-15 | |
| 2020-12-31 | 1.30M shares 10-K · filed 2022-03-31 | |
| 2016-06-30 | 1.38M shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 1.38M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 1.38M shares 10-Q · filed 2016-08-09 | |
| 2015-09-30 | 1.38M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 1.40M shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 1.40M shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 1.45M shares 10-K · filed 2016-03-15 | 1.40M shares 10-K · filed 2015-03-18 |
| 2014-09-30 | 1.45M shares 10-Q · filed 2014-11-10 | |
| 2014-06-30 | 1.40M shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 1.45M shares 10-Q · filed 2014-05-13 | |
| 2013-12-31 | 1.45M shares 10-K · filed 2015-03-18 | |
| 2013-09-30 | 1.56M shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 1.56M shares 10-Q · filed 2013-08-14 | |
| 2013-03-31 | 1.56M shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 1.56M shares 10-K · filed 2014-03-21 | |
| 2011-12-31 | 1.56M shares 10-K · filed 2013-03-29 | |
| 2010-12-31 | 1.59M shares 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |